• Home
  • An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.

Author List
Chaloupka FJ, Warner KE, Acemoglu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J
Publication
Tobacco control
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1186554
Publication Year
2014
PubMed ID
25550419
Publication Title
Chaloupka FJ, Warner KE, Acemoglu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tob Control. 2015 Mar; 24(2):112-9.